🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
The goal of this clinical trial is to learn about the tolerability of telmi...
Status
Recruiting
Location
Dartmouth Health
Start Date
2024-04-22
Trial ID
NCT06168487
Treatments Being Tested
26 patients with invasive primary transitional cell carcinoma of the bladde...
Status
Completed
Location
Bristol Haematology + Oncology Centre, Horfield Road
Start Date
2012-07-25
Trial ID
NCT01616875
Treatments Being Tested
There is no accepted standard chemotherapy approved for use in the second l...
Status
Completed
Location
National Cancer Institute
Start Date
2012-02-16
Trial ID
NCT01437488
Treatments Being Tested
Primary Objective: \- To evaluate the anti-tumor activity of cabazitaxel b...
Status
Completed
Location
Investigational Site Number 410001
Start Date
2011-12
Trial ID
NCT01497964
Treatments Being Tested
This is a Phase Ib/IIa Study of Cabazitaxel plus Bavituximab in patients wi...
Status
Terminated
Location
Medical University of South Carolina
Start Date
2011-06
Trial ID
NCT01335204
Treatments Being Tested
Primary Objective: \- To assess effectiveness of prophylactic treatment of...
Status
Completed
Location
Investigational Site Number 007
Start Date
2012-07
Trial ID
NCT01649635
Treatments Being Tested
Cabazitaxel is a second line chemotherapy drug recently approved for the tr...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT02882178
The purpose of the study was to understand if there is benefit in treatment...
Status
Terminated
Location
Site US10003
Start Date
2015-10-28
Trial ID
NCT02441517
Treatments Being Tested
This is a multicenter phase 2 open label study of pembrolizumab in patients...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-02-20
Trial ID
NCT03248570
Treatments Being Tested